Lexaria Bioscience is focused on the absorption, better flavour and improved delivery of compounds found in edible cannabis products.
Lexaria Bioscience Corp. is a food biosciences company with a proprietary technology for improved delivery of bio-active compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste.
Cannabinoids are poorly absorbed by the body’s gastrointestinal tract and consumers often default to alternate routes of administration like smoking to achieve higher effectiveness.
The Company’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.
Lexaria’s propiertary technology delivers the following advantages for cannabinoid edibles:
Masks taste – eliminates the strong tastes in cannabinoid edibles, enabling zero-sugar formats.
Reduces time of onset – effects are felt within 15-20 min vs. 60-120 min.
Increases bio-absorption – by 5 – 10X, to equate or excel that of inhalation.
For more information on Lexaria Bioscience (LXX.CN) please fill out the form below.